Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201806797
Publisher
Proceedings of the National Academy of Sciences
Online
2018-07-10
DOI
10.1073/pnas.1806797115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin ameliorates the in vitro efficacy of carfilzomib in human multiple myeloma U266 cells targeting p53 and NF-κB pathways
- (2018) Alessandro Allegra et al. TOXICOLOGY IN VITRO
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
- (2017) Jing Li et al. Nature Chemical Biology
- Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance
- (2017) Y Song et al. ONCOGENE
- Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
- (2015) Jonathan Bisson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis
- (2015) Xing Guo et al. NATURE CELL BIOLOGY
- Copper–zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma
- (2015) Kelley Salem et al. Redox Biology
- Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
- (2014) P. G. Richardson et al. BLOOD
- Farmer to pharmacist: curcumin as an anti-invasive and antimetastatic agent for the treatment of cancer1
- (2014) Debasish Bandyopadhyay Frontiers in Chemistry
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells
- (2013) Fabio Petrocca et al. CANCER CELL
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Increased proteasome activity in human embryonic stem cells is regulated by PSMD11
- (2012) David Vilchez et al. NATURE
- RPN-6 determines C. elegans longevity under proteotoxic stress conditions
- (2012) David Vilchez et al. NATURE
- Asymmetric Proteasome Segregation as a Mechanism for Unequal Partitioning of the Transcription Factor T-bet during T Lymphocyte Division
- (2011) John T. Chang et al. IMMUNITY
- Targeting the ubiquitin system in cancer therapy
- (2009) Daniela Hoeller et al. NATURE
- Curcumin Inhibits the Proteasome Activity in Human Colon Cancer Cells In vitro and In vivo
- (2008) V. Milacic et al. CANCER RESEARCH
- Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequentin vitro/in vivoevaluation
- (2008) Yasser Bustanji et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Ubiquitin, the proteasome and protein degradation in neuronal function and dysfunction
- (2008) Hwan-Ching Tai et al. NATURE REVIEWS NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search